Immatics NV (IMTX)
9.54
+0.08
(+0.85%)
USD |
NASDAQ |
Sep 04, 16:00
9.54
0.00 (0.00%)
After-Hours: 20:00
Immatics Cash and Short Term Investments (Annual) : 551.21M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 551.21M |
| December 31, 2024 | 625.91M |
| December 31, 2023 | 470.46M |
| December 31, 2022 | 386.56M |
| Date | Value |
|---|---|
| December 31, 2021 | 165.03M |
| December 31, 2020 | 283.84M |
| December 31, 2019 | 134.00M |
| December 31, 2018 | 59.98M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| MediGene AG | -- |
| InflaRx NV | 54.56M |
| BioNTech SE | 17.43B |
| Moderna, Inc. | 5.80B |
| Intellia Therapeutics, Inc. | 449.88M |